Ascentage Pharma Group International (AAPG) Current Leases (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Current Leases for 3 consecutive years, with $1.0 million as the latest value for Q4 2025.
- For Q4 2025, Current Leases fell 21.86% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, down 21.86%, while the annual FY2025 figure was $1.0 million, 19.49% down from the prior year.
- Current Leases hit $1.0 million in Q4 2025 for Ascentage Pharma Group International, down from $1.3 million in the prior quarter.
- Across five years, Current Leases topped out at $1.4 million in Q4 2023 and bottomed at $1.0 million in Q4 2025.
- Average Current Leases over 3 years is $1.2 million, with a median of $1.3 million recorded in 2024.
- Year-over-year, Current Leases fell 3.03% in 2024 and then dropped 21.86% in 2025.
- Ascentage Pharma Group International's Current Leases stood at $1.4 million in 2023, then decreased by 3.03% to $1.3 million in 2024, then decreased by 21.86% to $1.0 million in 2025.
- According to Business Quant data, Current Leases over the past three periods came in at $1.0 million, $1.3 million, and $1.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.